This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Media Center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Marketing & Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

70% of the world vaccinated against COVID-19 by 2022:

July 29, 2021
Capital to clinic: implementing policy during COVID-19
Oct. 11, 2021
Money matters on the road to vaccine equity
Sept. 22, 2021
PATH signs action plan against COVID-19 at the US Global COVID-19 Summit

Get breaking PATH updates

Featured Press Coverage

April 14, 2021
What the Coronavirus Variants Mean for Testing
View on The New York Times
Oct. 6, 2022
A ‘Historic Event’: First Malaria Vaccine Approved by W.H.O.
View on The New York Times
April 5, 2021
Researchers Are Hatching a Low-Cost Coronavirus Vaccine
View on The New York Times

Recent Press Coverage

  1. World's first malaria vaccine shows promise in Africa
    Ashley Birkett, director of PATH’s Malaria Vaccine Initiative, is quoted in this article highlighting early results on RTS,S (the world’s first malaria vaccine) and the potential impact of combining the vaccine with seasonal malaria chemoprevention.
    Published: September 2021
  2. The Wrong Way to Test Yourself for the Coronavirus
    Rapid tests can help you stay safe in the Delta outbreak. But you have to use them correctly. Neha Agarwal, associate director of PATH’s Diagnostics program, highlights infrastructure obstacles to accessing at-home testing.
    Published: August 2021
  3. COVID variants won't wait — we need to fund better vaccines ASAP
    PATH's Director of Advocacy and Public Policy Heather Ignatius writes about why funding CEPI is imperative to ensure the development of the vaccines we need — not only to control COVID-19 in the U.S. today, but to bring an end to the pandemic globally.
    Published: August 2021
  4. Why local expertise is key to PATH's new strategy
    Dr. Nanthalile Mugala, chief of the Africa region, speaks with Devex about PATH’s new five-year strategy and the importance of prioritizing local talent, local leadership, and local industry in global health programming.
    Published: August 2021
Next
Load more

PATH Newsroom

851 Items
851 Items
851 Items
    Date
  1. New HPV vaccine from Innovax receives WHO prequalification
    This important milestone will provide countries with an additional option for HPV vaccination at an affordable price and will contribute to sustainable supply of HPV vaccine—allowing more girls to be reached with HPV vaccines.
    Published: October 2021
    Type: Announcement
  2. Real-world performance of nOPV2 reinforces strong safety profile
    Experts endorse successful completion of initial use period
    Published: October 2021
    Type: Press Release
  3. USAID announces new five-year project to detect unknown viruses with pandemic potential
    Published: October 2021
    Type: Press Release
  4. PATH applauds WHO recommendation for broader use of first malaria vaccine
    Vaccine shown to be cost-effective and trusted by caregivers and health care workers
    Published: October 2021
    Type: Statement
  5. PATH signs action plan against COVID-19 at the US Global COVID-19 Summit
    PATH commits to helping vaccinate 70 percent of the world by September 2022, to saving lives now, and to better preparing the world for the next health threat.
    Published: September 2021
    Type: Press Release
Next
Load more